publication date: Nov. 18, 2016

In Brief

Libutti Named Director at Rutgers Cancer Institute

STEVEN LIBUTTI was appointed director of Rutgers Cancer Institute of New Jersey and will serve as Vice Chancellor for Cancer Programs for Rutgers Biomedical and Health Sciences at Rutgers University.

He will be the third permanent director in the 25-year history of Rutgers Cancer Institute of New Jersey and will take over next year for Bruce G. Haffty, MD, who has been serving as interim director and will continue his role as Chair of Radiation Oncology.

In addition to his leadership roles within Rutgers University, Libutti will serve as Senior Vice President of Oncology Services for RWJBarnabas Health, further strengthening the university’s partnership with the healthcare system. He will also have an appointment as a Professor of Surgery at Rutgers Robert Wood Johnson Medical School.

Libutti serves as director for the Montefiore Einstein Center for Cancer Care in New York and is professor and vice chairman of the Department of Surgery and Professor in the Department of Genetics at Albert Einstein College of Medicine and Montefiore Health System. A surgical oncologist, Libutti is an expert in endocrine surgery and the management of neuroendocrine tumors.

He is the immediate past president of the American Association of Endocrine Surgeons. His clinical practice focuses on gastrointestinal malignancies including cancers of the liver and pancreas.

The recipient of funding from the NCI for the past 20 years, Libutti is also a researcher whose work focuses on developing novel cancer therapies through an understanding of the tumor microenvironment and blood vessel formation in tumors.


MD ANDERSON Cancer Center established the Beau Biden Chair for Brain Cancer Research.

The endowed chair, which was announced during a … Continue reading Libutti Named Director at Rutgers Cancer Institute

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.